Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,298
Closed -$1.49M 286
2020
Q3
$1.49M Sell
6,298
-10,274
-62% -$2.34M 0.02% 420
2020
Q2
$3.29M Buy
16,572
+6,367
+62% +$1.19M 0.03% 320
2020
Q1
$1.87M Buy
+10,205
New +$1.82M 0.02% 347
2019
Q2
Sell
-109,988
Closed -$13.6M 620
2019
Q1
$13.6M Buy
109,988
+106,445
+3,004% +$13.4M 0.07% 211
2018
Q4
$415K Buy
+3,543
New +$418K ﹤0.01% 577
2016
Q3
Sell
-28,503
Closed -$1.44M 514
2016
Q2
$1.44M Sell
28,503
-4,400
-13% -$222K 0.01% 369
2016
Q1
$1.59M Buy
32,903
+999
+3% +$38.5K 0.01% 364
2015
Q4
$1.25M Buy
31,904
+26,200
+459% +$1.05M 0.01% 404
2015
Q3
$217K Sell
5,704
-5,636
-50% -$238K ﹤0.01% 491
2015
Q2
$451K Sell
11,340
-1,160
-9% -$36.1K ﹤0.01% 475
2015
Q1
$335K Buy
12,500
+1,300
+12% +$36.7K ﹤0.01% 452
2014
Q4
$329K Buy
+11,200
New +$277K ﹤0.01% 423

Other funds holding AMED

AJO LP's AMED Position: Q4 2020 in Review

AJO LP sold out of Amedisys (AMED) in Q4 2020, closing a stake of 6,298 shares — an estimated $1.49M sold.

AJO LP first reported a position in AMED in Q4 2014 and held it in 12 quarters. The position peaked at $13.6M in Q1 2019. 396 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • AJO LP reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 6,298 Amedisys shares in Q4 2020, an estimated $1.49M.
  • AJO LP first reported a position in Amedisys in Q4 2014 and held it in 12 quarters.
  • AJO LP's Amedisys position peaked at $13.6M in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.